A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO).
暂无分享，去创建一个
M. Suarez‐Almazor | D. Hafler | H. Tawbi | P. Ott | H. Kluger | C. Bingham | L. Chung | O. Rahma | B. Warner | M. Dougan | S. Wesley | E. Sharon | P. Reid | A. Khosroshahi | T. Katsumoto | Yinghong Wang | Sarthak Gupta | E. Dumbrava | L. Cappelli | J. Painter